The simple fact is that they need to decide how they will fund P3. Everything else is in place. We are all waiting on this direction. It will either be with a partner in some form or they will self finance and go alone.
Long term it probably doesn't matter which way. If they pass P3 and get FDA approval they win.
Short term a partnering deal is going to pump the share price, going alone is going to see it fall as people will invest elsewhere in the interim.
Near the bottom?, page-2
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.01 |
Change
-0.010(0.08%) |
Mkt cap ! $1.660B | |||
| Open | High | Low | Value | Volume |
| $13.06 | $13.26 | $12.81 | $5.844M | 450.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 505 | $13.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.02 | 2438 | 1 |
View Market Depth
| Last trade - 16.10pm 15/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |